Active Genetics & Molecular Biology Cells, Biochemistry & Physiology

RecombInsight: Discovery in Mammalian Homologous Recombination DNA Repair

In plain English

AI plain-English summary

Every time a cell divides, it must repair broken DNA strands with surgical precision, or risk becoming cancerous. This project focuses on the second, poorly understood phase of that repair process—homologous recombination—where the cell matches the broken DNA against an undamaged copy to restore it perfectly. The first phase of this repair is well mapped, but the subsequent steps remain a black box. Without knowing exactly which proteins orchestrate the later stages and how they handle the DNA, researchers cannot fully explain why certain genetic mutations cause premature ageing or dramatically raise cancer risk. This gap also limits the design of therapies that either exploit a cancer cell's faulty repair machinery or deliberately create toxic repair intermediates to kill tumours. This is fundamental science. The project will use chemistry, advanced genome editing, and new imaging techniques to identify the missing cellular factors and track the nucleic acid and protein events at each step. If successful, it will provide the molecular blueprint for a core DNA repair pathway. That blueprint could eventually guide the development of more targeted cancer treatments and clarify the mechanisms behind inherited cancer predisposition syndromes—but the immediate payoff is a deeper understanding of how our cells keep their genetic code intact.

View original technical description
Homologous Recombination DNA repair (HR) is the most accurate form of double-strand DNA break repair. Mutations in several genes that promote it are associated with human syndromes, including early-onset ageing and cancer predisposition. Targeting HR deficiency is at the core of several anti-cancer treatments while inducing toxic HR intermediates underpins an emerging therapeutic strategy. HR happens in two phases. The first involves trimming one of the broken DNA strands and is well understood. However, the next steps are mechanistic knowledge gaps, holding back understanding of cancer predisposition syndromes and new therapy developments. This project aims to discover the molecular details of this less-studied second phase of HR in mammalian cells. To achieve this it will identify new cellular factors that support the process and develop new means to assess the nucleic acid and protein events that occur at each step. The project will exploit concepts from chemistry, improved genome editing, innovative chromosome conformation and imaging technologies to deliver this step-change.

View the original record at the funder ↗

Researchers

Joanna Morris (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Mechanics and execution of homologous recombination - biophysics to the organism
Homologous Recombination at Human Centromeres: Friend or Foe?
A molecular understanding of homologous recombination in the context of chromatin
Combined genetic and biochemical approaches to uncover and characterize redundant factors involved in late stages of recombinational repair.
Mechanisms underpinning distinct manifestations of Homologous Recombination deficiency in cancer

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.